000 01150nam a2200337 a 4500
005 20250918164824.0
008 120711s2012 nyua 001 0 eng
020 _a9781604065855
_cRM423.19
039 9 _a201209200858
_bzaleha
_c201209051144
_dIzzati
_y07-11-2012
_zbalqis
040 _dUKM
090 _aWL140.B748 2012 9HUKM
090 _aWL140
_b.B748 2012 9HUKM
245 0 0 _aBotulinum neurotoxin for head and neck disorders /
_c[edited by] Andrew Blitzer, Brian E. Benson, Joel Guss.
260 _aNew York :
_bThieme,
_c2012.
300 _avii, 230 p. :
_bill. ;
_c26 cm.
650 2 _aNervous System Diseases
_xdrug therapy.
650 2 _aBotulinum Toxins
_xtherapeutic use.
650 2 _aNeuromuscular Agents
_xtherapeutic use.
650 2 _aHead.
650 2 _aNeck.
700 1 _aBlitzer, Andrew.
700 1 _aBenson, Brian E.
700 1 _aGuss, Joel.
907 _a.b15426051
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWL140.B748 2012 9HUKM
914 _avtls003507774
990 _aNHR/za
991 _aJabatan Otorinolaringologi, PPUKM
998 _ah
_b2012-11-07
_cm
_da
_feng
_gnyu
_y0
_z.b15426051
999 _c525995
_d525995